Brief: FDA Approves Vtama® Cream, 1% For The Treatment Of Atopic Dermatitis
16/12/2024 12:50
Dec 16 (Reuters) - Organon & Co OGN.N :
* FDA APPROVES VTAMA® (TAPINAROF) CREAM, 1% FOR THE
TREATMENT OF
ATOPIC DERMATITIS IN ADULTS AND CHILDREN 2 YEARS OF AGE AND
OLDER
Source text: ID:nBw3kvnjJa
Further company coverage: OGN.N
Recent news on Organon & Co.
See all newsIndia's Sun Pharma misses debt fundraise goal as investors demand higher yields, bankers say
Brief: Organon & Co Says It Does Not Expect To Record Milestone Expense In Q3 2026
India's Persistent Systems plans debut rupee debt sale to fund acquisition, bankers say
India's Sun Pharma plans $1 billion local debt sale for loan takeout, sources say
Organon & Co reports results for the quarter ended June 30 - Earnings Summary